HEALTHCOR MANAGEMENT, L.P. Holdings

HEALTHCOR MANAGEMENT, L.P. is an investment fund managing more than 799.58M US dollars. The largest holdings include BioMarin Pharmaceutical, AbbVie and Agilent Technologies. In Q3 2022 the fund bought assets of total value of 248.34M US dollars and sold assets of total value of 411.96M US dollars.

$799.58M

portfolio value

+4.46%

quarter

-5.26%

1 year

+34.05%

3 years

+46.86%

5 years

HEALTHCOR MANAGEMENT, L.P. portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	843856000	690543000
Q2 2016	806184000	756423000
Q3 2016	744338000	895151000
Q4 2016	952264000	870468000
Q1 2017	1151814000	678524000
Q2 2017	1193057000	732250000
Q3 2017	822466000	968355000
Q4 2017	1305827000	834985000
Q1 2018	1211139000	1164900000
Q2 2018	1130741000	870531000
Q3 2018	860978000	1001449000
Q4 2018	1010978000	1283296000
Q1 2019	1016129000	1366292000
Q2 2019	1206857000	980908000
Q3 2019	747708000	811066000
Q4 2019	1422932000	1072755000
Q1 2020	981242000	1413047000
Q2 2020	1164253000	1106768000
Q3 2020	1192137000	1105292000
Q4 2020	1026250000	1027636000
Q1 2021	1397152000	1193248000
Q2 2021	1082636000	1308087000
Q3 2021	798820000	928098000
Q4 2021	550332000	1039709000
Q1 2022	432431000	786570000
Q2 2022	165363000	635322000
Q3 2022	248337000	411963000

HEALTHCOR MANAGEMENT, L.P. 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 8.05% Portfolio value: 64.34M Avg. open price: $85.73 Current price: $103.53 P/L: +20.77% Bought +2.44% shares Q3 2022	share	8.05%	64.34M	$85.73	$103.53	+20.77%	Bought +2.44% shares Q3 2022
Drug Manufacturers—General AbbVie Inc. Portfolio share: 5.21% Portfolio value: 41.63M Avg. open price: $75.42 Current price: $163.96 P/L: +117.39% N/A Q3 2022	share	5.21%	41.63M	$75.42	$163.96	+117.39%	N/A Q3 2022
Diagnostics & Research Agilent Technologies, Inc. Portfolio share: 5.14% Portfolio value: 41.08M Avg. open price: $118.77 Current price: $150.01 P/L: +26.30% Bought +144.45% shares Q3 2022	share	5.14%	41.08M	$118.77	$150.01	+26.30%	Bought +144.45% shares Q3 2022
Medical Devices Boston Scientific Corporation Portfolio share: 4.64% Portfolio value: 37.12M Avg. open price: $36.42 Current price: $45.42 P/L: +24.70% Sold -46.98% shares Q3 2022	share	4.64%	37.12M	$36.42	$45.42	+24.70%	Sold -46.98% shares Q3 2022
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 4.17% Portfolio value: 33.35M Avg. open price: $324.23 Current price: $369.29 P/L: +13.90% Bought +46.04% shares Q3 2022	share	4.17%	33.35M	$324.23	$369.29	+13.90%	Bought +46.04% shares Q3 2022
Medical Distribution AmerisourceBergen Corporation Portfolio share: 4.05% Portfolio value: 32.36M Avg. open price: $116.86 Current price: $171.25 P/L: +46.55% Bought +52.41% shares Q3 2022	share	4.05%	32.36M	$116.86	$171.25	+46.55%	Bought +52.41% shares Q3 2022
Healthcare Plans UnitedHealth Group Incorporated Portfolio share: 3.98% Portfolio value: 31.80M Avg. open price: $236.95 Current price: $535.04 P/L: +125.80% Sold -7.69% shares Q3 2022	share	3.98%	31.80M	$236.95	$535.04	+125.80%	Sold -7.69% shares Q3 2022
Diagnostics & Research Danaher Corporation Portfolio share: 3.81% Portfolio value: 30.42M Avg. open price: $98.32 Current price: $267.97 P/L: +172.55% Bought +21.59% shares Q3 2022	share	3.81%	30.42M	$98.32	$267.97	+172.55%	Bought +21.59% shares Q3 2022
Medical Care Facilities Tenet Healthcare Corporation Portfolio share: 3.35% Portfolio value: 26.77M Avg. open price: $44.31 Current price: $44.6 P/L: +0.65% Bought +82.92% shares Q2 2022	share	3.35%	26.77M	$44.31	$44.6	+0.65%	Bought +82.92% shares Q2 2022
Diagnostics & Research Thermo Fisher Scientific Inc. Portfolio share: 3.25% Portfolio value: 25.98M Avg. open price: $282.69 Current price: $557.21 P/L: +97.11% N/A Q3 2022	share	3.25%	25.98M	$282.69	$557.21	+97.11%	N/A Q3 2022
Healthcare Plans Centene Corporation Portfolio share: 2.93% Portfolio value: 23.41M Avg. open price: N/A Current price: $86.35 P/L: N/A Sold -44.35% shares Q3 2022	share	2.93%	23.41M	N/A	$86.35	N/A	Sold -44.35% shares Q3 2022
Healthcare Plans CIGNA CORP NEW Portfolio share: 2.67% Portfolio value: 21.34M Avg. open price: N/A Current price: $327.39 P/L: N/A Sold -20.28% shares Q3 2022	share	2.67%	21.34M	N/A	$327.39	N/A	Sold -20.28% shares Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 2.63% Portfolio value: 21.05M Avg. open price: $40.77 Current price: $38.12 P/L: -6.51% Sold -10.51% shares Q3 2022	share	2.63%	21.05M	$40.77	$38.12	-6.51%	Sold -10.51% shares Q3 2022
Healthcare Plans Humana Inc. Portfolio share: 2.60% Portfolio value: 20.82M Avg. open price: $291.82 Current price: $547.42 P/L: +87.59% Sold -9.11% shares Q3 2022	share	2.60%	20.82M	$291.82	$547.42	+87.59%	Sold -9.11% shares Q3 2022
Biotechnology Syndax Pharmaceuticals, Inc. Portfolio share: 2.58% Portfolio value: 20.64M Avg. open price: $17.8 Current price: $25.44 P/L: +42.91% Sold -6.95% shares Q3 2022	share	2.58%	20.64M	$17.8	$25.44	+42.91%	Sold -6.95% shares Q3 2022
Medical Devices DexCom, Inc. Portfolio share: 2.55% Portfolio value: 20.41M Avg. open price: $108.95 Current price: $116.56 P/L: +6.98% Bought +238.99% shares Q3 2022	share	2.55%	20.41M	$108.95	$116.56	+6.98%	Bought +238.99% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 2.34% Portfolio value: 18.67M Avg. open price: $297.37 Current price: $292.75 P/L: -1.55% Sold -83.09% shares Q3 2022	share	2.34%	18.67M	$297.37	$292.75	-1.55%	Sold -83.09% shares Q3 2022
Healthcare Plans Elevance Health Inc. Portfolio share: 2.21% Portfolio value: 17.67M Avg. open price: N/A Current price: $522.34 P/L: N/A Sold -28.25% shares Q3 2022	share	2.21%	17.67M	N/A	$522.34	N/A	Sold -28.25% shares Q3 2022
Drug Manufacturers—General Amgen Inc. Portfolio share: 2.12% Portfolio value: 16.98M Avg. open price: $226.47 Current price: $285.01 P/L: +25.85% N/A Q3 2022	share	2.12%	16.98M	$226.47	$285.01	+25.85%	N/A Q3 2022
Medical Devices LivaNova PLC Portfolio share: 2.08% Portfolio value: 16.65M Avg. open price: $88.09 Current price: $55.1 P/L: -37.45% Sold -32.58% shares Q3 2022	share	2.08%	16.65M	$88.09	$55.1	-37.45%	Sold -32.58% shares Q3 2022
Medical Distribution Henry Schein, Inc. Portfolio share: 2.05% Portfolio value: 16.37M Avg. open price: $77.95 Current price: $81.47 P/L: +4.52% Sold -2.47% shares Q2 2022	share	2.05%	16.37M	$77.95	$81.47	+4.52%	Sold -2.47% shares Q2 2022
Drug Manufacturers—General Bristol-Myers Squibb Company Portfolio share: 1.98% Portfolio value: 15.86M Avg. open price: $59.42 Current price: $80.7 P/L: +35.82% Sold -45.89% shares Q3 2022	share	1.98%	15.86M	$59.42	$80.7	+35.82%	Sold -45.89% shares Q3 2022
Biotechnology Incyte Corporation Portfolio share: 1.90% Portfolio value: 15.18M Avg. open price: $94.24 Current price: $84.08 P/L: -10.78% Sold -2.68% shares Q3 2022	share	1.90%	15.18M	$94.24	$84.08	-10.78%	Sold -2.68% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 1.78% Portfolio value: 14.20M Avg. open price: $65.05 Current price: $98.48 P/L: +51.39% Sold -74.61% shares Q3 2022	share	1.78%	14.20M	$65.05	$98.48	+51.39%	Sold -74.61% shares Q3 2022
Medical Instruments & Supplies Becton, Dickinson and Company Portfolio share: 1.75% Portfolio value: 14.02M Avg. open price: $225.51 Current price: $246.21 P/L: +9.18% Bought +12.96% shares Q3 2022	share	1.75%	14.02M	$225.51	$246.21	+9.18%	Bought +12.96% shares Q3 2022
Biotechnology Kezar Life Sciences, Inc. Portfolio share: 1.73% Portfolio value: 13.84M Avg. open price: $8.27 Current price: $7.07 P/L: -14.51% Bought +32.88% shares Q3 2022	share	1.73%	13.84M	$8.27	$7.07	-14.51%	Bought +32.88% shares Q3 2022
Healthcare Plans CVS Health Corporation Portfolio share: 1.56% Portfolio value: 12.50M Avg. open price: $71.46 Current price: $102.01 P/L: +42.75% N/A Q3 2022	share	1.56%	12.50M	$71.46	$102.01	+42.75%	N/A Q3 2022
Medical Distribution McKesson Corporation Portfolio share: 1.49% Portfolio value: 11.90M Avg. open price: $192.98 Current price: $382.44 P/L: +98.17% Sold -63.42% shares Q2 2022	share	1.49%	11.90M	$192.98	$382.44	+98.17%	Sold -63.42% shares Q2 2022
Medical Devices Abbott Laboratories Portfolio share: 1.20% Portfolio value: 9.57M Avg. open price: $90.5 Current price: $105.38 P/L: +16.44% Sold -50.34% shares Q3 2022	share	1.20%	9.57M	$90.5	$105.38	+16.44%	Sold -50.34% shares Q3 2022
Healthcare Plans Molina Healthcare, Inc. Portfolio share: 1.14% Portfolio value: 9.08M Avg. open price: N/A Current price: $335.11 P/L: N/A N/A Q3 2022	share	1.14%	9.08M	N/A	$335.11	N/A	N/A Q3 2022
Medical Instruments & Supplies Hologic, Inc. Portfolio share: 1.11% Portfolio value: 8.86M Avg. open price: $50.49 Current price: $75.11 P/L: +48.76% Sold -65.85% shares Q3 2022	share	1.11%	8.86M	$50.49	$75.11	+48.76%	Sold -65.85% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 0.98% Portfolio value: 7.84M Avg. open price: N/A Current price: $121.22 P/L: N/A Sold -44.36% shares Q3 2022	share	0.98%	7.84M	N/A	$121.22	N/A	Sold -44.36% shares Q3 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 0.89% Portfolio value: 7.10M Avg. open price: N/A Current price: $19.03 P/L: N/A N/A Q3 2022	share	0.89%	7.10M	N/A	$19.03	N/A	N/A Q3 2022
Biotechnology Blueprint Medicines Corporation Portfolio share: 0.86% Portfolio value: 6.89M Avg. open price: $82.8 Current price: $50.19 P/L: -39.39% N/A Q3 2022	share	0.86%	6.89M	$82.8	$50.19	-39.39%	N/A Q3 2022
Medical Devices Inspire Medical Systems, Inc. Portfolio share: 0.85% Portfolio value: 6.78M Avg. open price: N/A Current price: $234.96 P/L: N/A N/A Q3 2022	share	0.85%	6.78M	N/A	$234.96	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Alkermes plc Portfolio share: 0.85% Portfolio value: 6.77M Avg. open price: N/A Current price: $25.51 P/L: N/A N/A Q3 2022	share	0.85%	6.77M	N/A	$25.51	N/A	N/A Q3 2022
Biotechnology ImmunoGen, Inc. Portfolio share: 0.78% Portfolio value: 6.21M Avg. open price: $5.18 Current price: $5.43 P/L: +4.83% Bought +160.00% shares Q3 2022	share	0.78%	6.21M	$5.18	$5.43	+4.83%	Bought +160.00% shares Q3 2022
Medical Devices ShockWave Medical, Inc. Portfolio share: 0.69% Portfolio value: 5.48M Avg. open price: N/A Current price: $243.11 P/L: N/A N/A Q3 2022	share	0.69%	5.48M	N/A	$243.11	N/A	N/A Q3 2022
Biotechnology Merus N.V. Portfolio share: 0.68% Portfolio value: 5.46M Avg. open price: $22.38 Current price: $14.2 P/L: -36.56% Bought +128.93% shares Q3 2022	share	0.68%	5.46M	$22.38	$14.2	-36.56%	Bought +128.93% shares Q3 2022
Biotechnology Chinook Therapeutics, Inc. Portfolio share: 0.66% Portfolio value: 5.24M Avg. open price: N/A Current price: $22.77 P/L: N/A N/A Q3 2022	share	0.66%	5.24M	N/A	$22.77	N/A	N/A Q3 2022
Medical Instruments & Supplies DENTSPLY SIRONA Inc. Portfolio share: 0.56% Portfolio value: 4.48M Avg. open price: N/A Current price: $30.63 P/L: N/A N/A Q3 2022	share	0.56%	4.48M	N/A	$30.63	N/A	N/A Q3 2022
Biotechnology Geron Corporation Portfolio share: 0.56% Portfolio value: 4.45M Avg. open price: $1.53 Current price: $2.29 P/L: +49.57% Bought +90.42% shares Q3 2022	share	0.56%	4.45M	$1.53	$2.29	+49.57%	Bought +90.42% shares Q3 2022
Biotechnology Affimed N.V. Portfolio share: 0.44% Portfolio value: 3.54M Avg. open price: $7.99 Current price: $2.12 P/L: -73.53% Sold -32.63% shares Q4 2021	share	0.44%	3.54M	$7.99	$2.12	-73.53%	Sold -32.63% shares Q4 2021
Medical Care Facilities Cano Health, Inc. Portfolio share: 0.43% Portfolio value: 3.43M Avg. open price: N/A Current price: $2.09 P/L: N/A N/A Q3 2022	share	0.43%	3.43M	N/A	$2.09	N/A	N/A Q3 2022
Diagnostics & Research NeoGenomics, Inc. Portfolio share: 0.42% Portfolio value: 3.36M Avg. open price: N/A Current price: $11.8 P/L: N/A N/A Q3 2022	share	0.42%	3.36M	N/A	$11.8	N/A	N/A Q3 2022
Medical Devices Nevro Corp. Portfolio share: 0.39% Portfolio value: 3.15M Avg. open price: $87.47 Current price: $43.47 P/L: -50.30% N/A Q3 2022	share	0.39%	3.15M	$87.47	$43.47	-50.30%	N/A Q3 2022
Biotechnology bluebird bio, Inc. Portfolio share: 0.36% Portfolio value: 2.88M Avg. open price: $75.23 Current price: $8.01 P/L: -89.35% N/A Q3 2022	share	0.36%	2.88M	$75.23	$8.01	-89.35%	N/A Q3 2022
Diagnostics & Research Natera, Inc. Portfolio share: 0.36% Portfolio value: 2.85M Avg. open price: $93.39 Current price: $40.39 P/L: -56.75% Sold -92.75% shares Q3 2022	share	0.36%	2.85M	$93.39	$40.39	-56.75%	Sold -92.75% shares Q3 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 0.29% Portfolio value: 2.30M Avg. open price: $80.63 Current price: $124 P/L: +53.79% N/A Q3 2022	share	0.29%	2.30M	$80.63	$124	+53.79%	N/A Q3 2022
Medical Devices Hyperfine, Inc. Portfolio share: 0.28% Portfolio value: 2.22M Avg. open price: $5.36 Current price: $0.73 P/L: -86.33% Bought +57.11% shares Q2 2022	share	0.28%	2.22M	$5.36	$0.73	-86.33%	Bought +57.11% shares Q2 2022
Biotechnology Revance Therapeutics, Inc. Portfolio share: 0.22% Portfolio value: 1.74M Avg. open price: $27.86 Current price: $21.1 P/L: -24.26% Sold -95.45% shares Q3 2022	share	0.22%	1.74M	$27.86	$21.1	-24.26%	Sold -95.45% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.19% Portfolio value: 1.52M Avg. open price: N/A Current price: $21.89 P/L: N/A N/A Q3 2022	share	0.19%	1.52M	N/A	$21.89	N/A	N/A Q3 2022
Biotechnology Leap Therapeutics, Inc. Portfolio share: 0.12% Portfolio value: 939K Avg. open price: N/A Current price: $0.52 P/L: N/A Sold -11.11% shares Q4 2021	share	0.12%	939K	N/A	$0.52	N/A	Sold -11.11% shares Q4 2021
Biotechnology Ikena Oncology, Inc. Portfolio share: 0.10% Portfolio value: 781K Avg. open price: $28.25 Current price: $2.23 P/L: -92.11% Sold -23.48% shares Q2 2022	share	0.10%	781K	$28.25	$2.23	-92.11%	Sold -23.48% shares Q2 2022
Biotechnology EQRx, Inc. Portfolio share: 0.00% Portfolio value: 29K Avg. open price: N/A Current price: $0.5 P/L: N/A Sold -64.76% shares Q3 2022	share	0.00%	29K	N/A	$0.5	N/A	Sold -64.76% shares Q3 2022
LONGVIEW ACQUISITION CORP II Portfolio share: 0.00% Portfolio value: 10K Avg. open price: N/A Current price: N/A P/L: N/A Sold -64.89% shares Q3 2022	share	0.00%	10K	N/A	N/A	N/A	Sold -64.89% shares Q3 2022
EUCRATES BIOMEDICAL ACQU COR Portfolio share: 0.00% Portfolio value: 2K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.00%	2K	N/A	N/A	N/A	N/A Q4 2021
Medicus Sciences Acquisition Corp. Portfolio share: 0.00% Portfolio value: 1K Avg. open price: N/A Current price: $0.09 P/L: N/A Sold -63.98% shares Q3 2022	share	0.00%	1K	N/A	$0.09	N/A	Sold -63.98% shares Q3 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $34.43 Current price: $51.99 P/L: +50.99% Sold -100.00% shares Q3 2022	call	0.00%	0	$34.43	$51.99	+50.99%	Sold -100.00% shares Q3 2022
Medical Devices Insulet Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $302.43 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$302.43	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Intra-Cellular Therapies, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $61.19 Current price: $54.25 P/L: -11.34% Sold -100.00% shares Q3 2022	share	0.00%	0	$61.19	$54.25	-11.34%	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies Intuitive Surgical, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $154.64 Current price: $269.72 P/L: +74.42% Sold -100.00% shares Q3 2022	share	0.00%	0	$154.64	$269.72	+74.42%	Sold -100.00% shares Q3 2022
iShares Biotechnology ETF Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $130.3 Current price: $135.49 P/L: +3.98% Sold -100.00% shares Q3 2022	share	0.00%	0	$130.3	$135.49	+3.98%	Sold -100.00% shares Q3 2022
Biotechnology Galapagos NV Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $64.7 Current price: $38.92 P/L: -39.84% Sold -100.00% shares Q3 2022	share	0.00%	0	$64.7	$38.92	-39.84%	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies The Cooper Companies, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $355.74 Current price: $321.56 P/L: -9.61% Sold -100.00% shares Q3 2022	share	0.00%	0	$355.74	$321.56	-9.61%	Sold -100.00% shares Q3 2022
Orion Acquisition Corp. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0	N/A	Sold -100.00% shares Q3 2022
Medical Devices Quanterix Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $42.26 Current price: $13 P/L: -69.24% Sold -100.00% shares Q3 2022	share	0.00%	0	$42.26	$13	-69.24%	Sold -100.00% shares Q3 2022
Biotechnology RAPT Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $36.28 Current price: $16.53 P/L: -54.44% Sold -100.00% shares Q3 2022	share	0.00%	0	$36.28	$16.53	-54.44%	Sold -100.00% shares Q3 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $34.43 Current price: $51.99 P/L: +50.99% Sold -100.00% shares Q3 2022	share	0.00%	0	$34.43	$51.99	+50.99%	Sold -100.00% shares Q3 2022
Health Care Select Sector SPDR Fund Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $138.43 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$138.43	N/A	Sold -100.00% shares Q3 2022
Medical Devices Boston Scientific Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $36.42 Current price: $45.42 P/L: +24.70% Sold -100.00% shares Q3 2022	call	0.00%	0	$36.42	$45.42	+24.70%	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Teva Pharmaceutical Industries Limited Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $8.62 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$8.62	N/A	Sold -100.00% shares Q3 2022
Medical Care Facilities Universal Health Services, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $119.31 Current price: $127.36 P/L: +6.74% Sold -100.00% shares Q3 2022	share	0.00%	0	$119.31	$127.36	+6.74%	Sold -100.00% shares Q3 2022
Medical Devices Zimmer Biomet Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $117.8 Current price: $122.3 P/L: +3.82% Sold -100.00% shares Q3 2022	share	0.00%	0	$117.8	$122.3	+3.82%	Sold -100.00% shares Q3 2022
Biotechnology BioCryst Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $15.82 Current price: $11.58 P/L: -26.79% Sold -100.00% shares Q3 2022	share	0.00%	0	$15.82	$11.58	-26.79%	Sold -100.00% shares Q3 2022
Medical Devices Align Technology, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $140.97 Current price: $187.96 P/L: +33.34% Sold -100.00% shares Q3 2022	call	0.00%	0	$140.97	$187.96	+33.34%	Sold -100.00% shares Q3 2022

Showing TOP 76 HEALTHCOR MANAGEMENT, L.P.'s 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of HEALTHCOR MANAGEMENT, L.P.?

The biggest position of the HEALTHCOR MANAGEMENT, L.P. is BioMarin Pharmaceutical Inc. (BMRN) with 8.05% portfolio share worth of 64.34M US dollars.

Top 5 HEALTHCOR MANAGEMENT, L.P.'s holdings represent 27.21% of the portfolio:

BioMarin Pharmaceutical Inc. (BMRN) – 8.05%
AbbVie Inc. (ABBV) – 5.21%
Agilent Technologies, Inc. (A) – 5.14%
Boston Scientific Corporation (BSX) – 4.64%
Eli Lilly and Company (LLY) – 4.17%

Who is the portfolio manager of HEALTHCOR MANAGEMENT, L.P.?

The portfolio manager of the HEALTHCOR MANAGEMENT, L.P. is .

What is the total asset value of the HEALTHCOR MANAGEMENT, L.P. portfolio?

HEALTHCOR MANAGEMENT, L.P. total asset value (portfolio value) is 799.58M US dollars.

Who is ?

is the portfolio manager of the HEALTHCOR MANAGEMENT, L.P..

What is (HEALTHCOR MANAGEMENT, L.P.) fund performance?

HEALTHCOR MANAGEMENT, L.P.'s quarterly performance is +4.46%, annualy -5.26%. In the past 3 years, the value of 's portfolio has increased by +34%. In the past 5 years, the value of the portfolio has increased by +47%.

What is the HEALTHCOR MANAGEMENT, L.P. CIK?

HEALTHCOR MANAGEMENT, L.P.'s Central Index Key is 0001343781 .

HEALTHCOR MANAGEMENT, L.P. Holdings

HEALTHCOR MANAGEMENT, L.P. portfolio value:

HEALTHCOR MANAGEMENT, L.P. quarter portfolio value change:

HEALTHCOR MANAGEMENT, L.P. 1 year portfolio value change:

HEALTHCOR MANAGEMENT, L.P. 3 years portfolio value change:

HEALTHCOR MANAGEMENT, L.P. 5 years portfolio value change: